UK Markets closed
  • NIKKEI 225

    29,255.55
    +40.03 (+0.14%)
     
  • HANG SENG

    26,136.02
    +348.81 (+1.35%)
     
  • GOLD FUTURES

    1,786.00
    +15.50 (+0.88%)
     
  • DOW

    35,612.43
    +155.12 (+0.44%)
     
  • BTC-GBP

    47,985.64
    +1,862.74 (+4.04%)
     
  • CMC Crypto 200

    1,544.68
    +63.88 (+4.31%)
     
  • Nasdaq

    15,107.42
    -21.67 (-0.14%)
     
  • ^FTAS

    4,118.78
    -0.40 (-0.01%)
     

3 reasons why FDA advisors rejected Pfizer’s booster for the general public

In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Meg Fitzgerald, “Ascending Davos” Author and Columbia University Healthcare Policy Professor, joins Yahoo Finance Live to discuss the future of vaccines, the FDA rejecting Pfizer's booster shot for the general public and the importance of getting young children vaccinated as soon as possible.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting